![QBV QBV](https://data.pdbj.org/pdbjplus/data/cc/svg/QBV.svg) | QBV | Name: | (2E)-3-(3-bromo-4-hydroxyphenyl)prop-2-enoic acid | Formula: | C9 H7 Br O3 | SMILES: | C([C@H]=Cc1ccc(c(c1)Br)O)(O)=O | InChi: | InChI=1S/C9H7BrO3/c10-7-5-6(1-3-8(7)11)2-4-9(12)13/h1-5,11H,(H,12,13)/b4-2+ | Definition date: | 2019-10-11 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2E)-3-(3-bromo-4-hydroxyphenyl)prop-2-enoic acid |
|
![QD2 QD2](https://data.pdbj.org/pdbjplus/data/cc/svg/QD2.svg) | QD2 | Name: | 4-[6-methoxy-5-(methylsulfamoyl)pyridin-3-yl]-~{N}-(1-methylpiperidin-4-yl)-2,3-dihydro-1,4-benzoxazine-6-carboxamide | Formula: | C22 H29 N5 O5 S | SMILES: | CN[S](=O)(=O)c1cc(cnc1OC)N2CCOc3ccc(cc23)C(=O)NC4CCN(C)CC4 | InChi: | InChI=1S/C22H29N5O5S/c1-23-33(29,30)20-13-17(14-24-22(20)31-3)27-10-11-32-19-5-4-15(12-18(19)27)21(28)25-16-6-8-26(2)9-7-16/h4-5,12-14,16,23H,6-11H2,1-3H3,(H,25,28) | Definition date: | 2020-06-08 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 4-[6-methoxy-5-(methylsulfamoyl)pyridin-3-yl]-~{N}-(1-methylpiperidin-4-yl)-2,3-dihydro-1,4-benzoxazine-6-carboxamide |
|
![QGM QGM](https://data.pdbj.org/pdbjplus/data/cc/svg/QGM.svg) | QGM | Name: | (2R,4S)-5,7-dichloro-4-[(phenylcarbamoyl)amino]-1,2,3,4-tetrahydroquinoline-2-carboxylic acid | Formula: | C17 H15 Cl2 N3 O3 | SMILES: | N1c3c(C(CC1C(O)=O)NC(Nc2ccccc2)=O)c(cc(c3)Cl)Cl | InChi: | InChI=1S/C17H15Cl2N3O3/c18-9-6-11(19)15-12(7-9)21-14(16(23)24)8-13(15)22-17(25)20-10-4-2-1-3-5-10/h1-7,13-14,21H,8H2,(H,23,24)(H2,20,22,25)/t13-,14+/m0/s1 | Definition date: | 2019-10-29 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2R,4S)-5,7-dichloro-4-[(phenylcarbamoyl)amino]-1,2,3,4-tetrahydroquinoline-2-carboxylic acid |
|
![QGP QGP](https://data.pdbj.org/pdbjplus/data/cc/svg/QGP.svg) | QGP | Name: | (2S)-2-amino-3-[2',4'-dichloro-4-hydroxy-5-(phosphonomethyl)biphenyl-3-yl]propanoic acid | Formula: | C16 H16 Cl2 N O6 P | SMILES: | c2(c(CP(O)(=O)O)cc(c1c(cc(Cl)cc1)Cl)cc2CC(N)C(O)=O)O | InChi: | InChI=1S/C16H16Cl2NO6P/c17-11-1-2-12(13(18)6-11)8-3-9(5-14(19)16(21)22)15(20)10(4-8)7-26(23,24)25/h1-4,6,14,20H,5,7,19H2,(H,21,22)(H2,23,24,25)/t14-/m0/s1 | Definition date: | 2019-10-29 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2S)-2-amino-3-[2',4'-dichloro-4-hydroxy-5-(phosphonomethyl)biphenyl-3-yl]propanoic acid (non-preferred name) |
|
![QLQ QLQ](https://data.pdbj.org/pdbjplus/data/cc/svg/QLQ.svg) | QLQ | Name: | ~{N}-[(2~{R})-3-(7-methyl-2~{H}-indazol-5-yl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-piperidin-4-yl-1-(4-pyridin-4-ylpiperazin-1-yl)propan-2-yl]amino]propan-2-yl]-2-oxidanylidene-spiro[1~{H}-pyrido[2,3-d][1,3]oxazine-4,4'-piperidine]-1'-carboxamide | Formula: | C40 H49 N11 O5 | SMILES: | Cc1cc(C[CH](NC(=O)N2CCC3(CC2)OC(=O)Nc4ncccc34)C(=O)N[CH](CC5CCNCC5)C(=O)N6CCN(CC6)c7ccncc7)cc8c[nH]nc18 | InChi: | InChI=1S/C40H49N11O5/c1-26-21-28(22-29-25-44-48-34(26)29)24-32(46-38(54)51-15-8-40(9-16-51)31-3-2-10-43-35(31)47-39(55)56-40)36(52)45-33(23-27-4-11-41-12-5-27)37(53)50-19-17-49(18-20-50)30-6-13-42-14-7-30/h2-3,6-7,10,13-14,21-22,25,27,32-33,41H,4-5,8-9,11-12,15-20,23-24H2,1H3,(H,44,48)(H,45,52)(H,46,54)(H,43,47,55)/t32-,33+/m1/s1 | Definition date: | 2020-06-24 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | ~{N}-[(2~{R})-3-(7-methyl-2~{H}-indazol-5-yl)-1-oxidanylidene-1-[[(2~{S})-1-oxidanylidene-3-piperidin-4-yl-1-(4-pyridin-4-ylpiperazin-1-yl)propan-2-yl]amino]propan-2-yl]-2-oxidanylidene-spiro[1~{H}-pyrido[2,3-d][1,3]oxazine-4,4'-piperidine]-1'-carboxamide |
|
![QWY QWY](https://data.pdbj.org/pdbjplus/data/cc/svg/QWY.svg) | QWY | Name: | 3-amino-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide | Formula: | C21 H19 N5 O S2 | SMILES: | c1ccccc1c2sc(nn2)NC(=O)c5sc3c(cc4c(n3)CCCCC4)c5N | InChi: | InChI=1S/C21H19N5OS2/c22-16-14-11-13-9-5-2-6-10-15(13)23-20(14)28-17(16)18(27)24-21-26-25-19(29-21)12-7-3-1-4-8-12/h1,3-4,7-8,11H,2,5-6,9-10,22H2,(H,24,26,27) | Definition date: | 2020-01-09 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 3-amino-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide |
|
![RJY RJY](https://data.pdbj.org/pdbjplus/data/cc/svg/RJY.svg) | RJY | Name: | ethyl 2-methyl-1,3-thiazole-4-carboxylate | Formula: | C7 H9 N O2 S | SMILES: | Cc1scc(C(=O)OCC)n1 | InChi: | InChI=1S/C7H9NO2S/c1-3-10-7(9)6-4-11-5(2)8-6/h4H,3H2,1-2H3 | Definition date: | 2020-02-13 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | ethyl 2-methyl-1,3-thiazole-4-carboxylate |
|
![RK4 RK4](https://data.pdbj.org/pdbjplus/data/cc/svg/RK4.svg) | RK4 | Name: | 3-[(piperidin-1-yl)methyl]benzoic acid | Formula: | C13 H17 N O2 | SMILES: | C1CCN(CC1)Cc2cccc(C(=O)O)c2 | InChi: | InChI=1S/C13H17NO2/c15-13(16)12-6-4-5-11(9-12)10-14-7-2-1-3-8-14/h4-6,9H,1-3,7-8,10H2,(H,15,16) | Definition date: | 2020-02-13 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 3-[(piperidin-1-yl)methyl]benzoic acid |
|
![RKV RKV](https://data.pdbj.org/pdbjplus/data/cc/svg/RKV.svg) | RKV | Name: | 3-(furan-2-yl)-1-methyl-1H-pyrazole-5-carboxylic acid | Formula: | C9 H8 N2 O3 | SMILES: | c1c(n(nc1c2ccco2)C)C(O)=O | InChi: | InChI=1S/C9H8N2O3/c1-11-7(9(12)13)5-6(10-11)8-3-2-4-14-8/h2-5H,1H3,(H,12,13) | Definition date: | 2020-02-13 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 3-(furan-2-yl)-1-methyl-1H-pyrazole-5-carboxylic acid |
|
![RKY RKY](https://data.pdbj.org/pdbjplus/data/cc/svg/RKY.svg) | RKY | Name: | 4-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-4-oxobutanoic acid | Formula: | C13 H14 O5 | SMILES: | c1cc(C(CCC(O)=O)=O)cc2c1OCCCO2 | InChi: | InChI=1S/C13H14O5/c14-10(3-5-13(15)16)9-2-4-11-12(8-9)18-7-1-6-17-11/h2,4,8H,1,3,5-7H2,(H,15,16) | Definition date: | 2020-02-13 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 4-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-4-oxobutanoic acid |
|
![RPJ RPJ](https://data.pdbj.org/pdbjplus/data/cc/svg/RPJ.svg) | RPJ | Name: | 1-(4-fluorophenyl)-5-[3-(1H-indol-3-yl)propoxy]-1H-pyrazole-4-carboxylic acid | Formula: | C21 H18 F N3 O3 | SMILES: | c4cc(n1c(c(C(O)=O)cn1)OCCCc2cnc3ccccc23)ccc4F | InChi: | InChI=1S/C21H18FN3O3/c22-15-7-9-16(10-8-15)25-20(18(13-24-25)21(26)27)28-11-3-4-14-12-23-19-6-2-1-5-17(14)19/h1-2,5-10,12-13,23H,3-4,11H2,(H,26,27) | Definition date: | 2020-02-20 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 1-(4-fluorophenyl)-5-[3-(1H-indol-3-yl)propoxy]-1H-pyrazole-4-carboxylic acid |
|
![RPM RPM](https://data.pdbj.org/pdbjplus/data/cc/svg/RPM.svg) | RPM | Name: | 5-[3-(5-methyl-1H-indol-3-yl)propoxy]-1-phenyl-1H-pyrazole-4-carboxylic acid | Formula: | C22 H21 N3 O3 | SMILES: | C(COc2n(c1ccccc1)ncc2C(O)=O)Cc4cnc3ccc(cc34)C | InChi: | InChI=1S/C22H21N3O3/c1-15-9-10-20-18(12-15)16(13-23-20)6-5-11-28-21-19(22(26)27)14-24-25(21)17-7-3-2-4-8-17/h2-4,7-10,12-14,23H,5-6,11H2,1H3,(H,26,27) | Definition date: | 2020-02-20 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 5-[3-(5-methyl-1H-indol-3-yl)propoxy]-1-phenyl-1H-pyrazole-4-carboxylic acid |
|
![RPV RPV](https://data.pdbj.org/pdbjplus/data/cc/svg/RPV.svg) | RPV | Name: | 5-{[3-(1H-indol-3-yl)propanoyl]amino}-1-phenyl-1H-pyrazole-4-carboxylic acid | Formula: | C21 H18 N4 O3 | SMILES: | c1cc(ccc1)n2ncc(C(O)=O)c2NC(CCc4c3c(cccc3)nc4)=O | InChi: | InChI=1S/C21H18N4O3/c26-19(11-10-14-12-22-18-9-5-4-8-16(14)18)24-20-17(21(27)28)13-23-25(20)15-6-2-1-3-7-15/h1-9,12-13,22H,10-11H2,(H,24,26)(H,27,28) | Definition date: | 2020-02-20 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 5-{[3-(1H-indol-3-yl)propanoyl]amino}-1-phenyl-1H-pyrazole-4-carboxylic acid |
|
![RQ1 RQ1](https://data.pdbj.org/pdbjplus/data/cc/svg/RQ1.svg) | RQ1 | Name: | 5-[4-(1H-indol-3-yl)butoxy]-1-phenyl-1H-pyrazole-4-carboxylic acid | Formula: | C22 H21 N3 O3 | SMILES: | c1cccc(c1)n2c(c(C(O)=O)cn2)OCCCCc4c3ccccc3nc4 | InChi: | InChI=1S/C22H21N3O3/c26-22(27)19-15-24-25(17-9-2-1-3-10-17)21(19)28-13-7-6-8-16-14-23-20-12-5-4-11-18(16)20/h1-5,9-12,14-15,23H,6-8,13H2,(H,26,27) | Definition date: | 2020-02-20 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 5-[4-(1H-indol-3-yl)butoxy]-1-phenyl-1H-pyrazole-4-carboxylic acid |
|
![RQ4 RQ4](https://data.pdbj.org/pdbjplus/data/cc/svg/RQ4.svg) | RQ4 | Name: | 6-methyl-5-(4-phenyl-1,3-thiazol-2-yl)-2-(trifluoromethyl)pyridine-3-carboxylic acid | Formula: | C17 H11 F3 N2 O2 S | SMILES: | Cc1c(cc(C(O)=O)c(n1)C(F)(F)F)c3scc(c2ccccc2)n3 | InChi: | InChI=1S/C17H11F3N2O2S/c1-9-11(7-12(16(23)24)14(21-9)17(18,19)20)15-22-13(8-25-15)10-5-3-2-4-6-10/h2-8H,1H3,(H,23,24) | Definition date: | 2020-02-20 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 6-methyl-5-(4-phenyl-1,3-thiazol-2-yl)-2-(trifluoromethyl)pyridine-3-carboxylic acid |
|
![PKB PKB](https://data.pdbj.org/pdbjplus/data/cc/svg/PKB.svg) | PKB | Name: | 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-~{N}-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine | Formula: | C20 H17 F3 N6 O2 | SMILES: | CCOc1ccc2n(ncc2c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3)n1 | InChi: | InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27) | Definition date: | 2020-04-24 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-~{N}-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine |
|
![MQH MQH](https://data.pdbj.org/pdbjplus/data/cc/svg/MQH.svg) | MQH | Name: | Bottromycin A2 | Formula: | C42 H62 N8 O7 S | SMILES: | COC(=O)C[CH](NC(=O)[CH](NC(=O)[CH](N=C1NCC(=O)N2CC[CH](C)[CH]2C(=O)N[CH](C(C)C)C(=O)N[CH]1C(C)(C)C)C(C)(C)C)[CH](C)c3ccccc3)c4sccn4 | InChi: | InChI=1S/C42H62N8O7S/c1-23(2)30-36(53)49-33(41(5,6)7)35(44-22-28(51)50-19-17-24(3)32(50)38(55)46-30)48-34(42(8,9)10)39(56)47-31(25(4)26-15-13-12-14-16-26)37(54)45-27(21-29(52)57-11)40-43-18-20-58-40/h12-16,18,20,23-25,27,30-34H,17,19,21-22H2,1-11H3,(H,44,48)(H,45,54)(H,46,55)(H,47,56)(H,49,53)/t24-,25+,27-,30+,31+,32+,33-,34-/m1/s1 | Definition date: | 2019-10-21 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | methyl (3~{R})-3-[[(2~{S},3~{S})-2-[[(2~{S})-2-[(~{E})-[(6~{S},9~{S},12~{S},13~{R})-6-~{tert}-butyl-13-methyl-2,8,11-tris(oxidanylidene)-9-propan-2-yl-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-5-ylidene]amino]-3,3-dimethyl-butanoyl]amino]-3-phenyl-butanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate |
|
![MQW MQW](https://data.pdbj.org/pdbjplus/data/cc/svg/MQW.svg) | MQW | Name: | (4~{R})-2-[(1~{R})-1-[[(2~{S})-2-[[(2~{S})-3-methyl-2-[[(4~{Z},6~{S},9~{S},12~{S})-2,8,11-tris(oxidanylidene)-6,9-di(propan-2-yl)-1,4,7,10-tetrazabicyclo[10.3.0]pentadec-4-en-5-yl]amino]butanoyl]amino]-3-phenyl-propanoyl]amino]-3-oxidanyl-3-oxidanylidene-propyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid | Formula: | C38 H54 N8 O9 S | SMILES: | CC(C)[CH]1NC(=O)[CH]2CCCN2C(=O)CN=C(N[CH](C(C)C)C(=O)N[CH](Cc3ccccc3)C(=O)N[CH](CC(O)=O)C4=N[CH](CS4)C(O)=O)[CH](NC1=O)C(C)C | InChi: | InChI=1S/C38H54N8O9S/c1-19(2)29-32(39-17-27(47)46-14-10-13-26(46)34(51)45-31(21(5)6)36(53)44-29)43-30(20(3)4)35(52)40-23(15-22-11-8-7-9-12-22)33(50)41-24(16-28(48)49)37-42-25(18-56-37)38(54)55/h7-9,11-12,19-21,23-26,29-31H,10,13-18H2,1-6H3,(H,39,43)(H,40,52)(H,41,50)(H,44,53)(H,45,51)(H,48,49)(H,54,55)/t23-,24+,25-,26-,29-,30-,31-/m0/s1 | Definition date: | 2019-10-21 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (4~{R})-2-[(1~{R})-1-[[(2~{S})-2-[[(2~{S})-3-methyl-2-[[(4~{Z},6~{S},9~{S},12~{S})-2,8,11-tris(oxidanylidene)-6,9-di(propan-2-yl)-1,4,7,10-tetrazabicyclo[10.3.0]pentadec-4-en-5-yl]amino]butanoyl]amino]-3-phenyl-propanoyl]amino]-3-oxidanyl-3-oxidanylidene-propyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
|
![MQZ MQZ](https://data.pdbj.org/pdbjplus/data/cc/svg/MQZ.svg) | MQZ | Name: | Bottromycin A2 derivative | Formula: | C42 H62 N8 O8 S2 | SMILES: | COC(=O)C[CH](NC(=O)[CH](NC(=O)[CH](N=C1NCC(=O)N2CC[CH](C)[CH]2C(=O)N[CH](CC[S](C)=O)C(=O)N[CH]1C(C)(C)C)C(C)(C)C)[CH](C)c3ccccc3)c4sccn4 | InChi: | InChI=1S/C42H62N8O8S2/c1-24-16-19-50-29(51)23-44-35(33(41(3,4)5)49-36(53)27(17-21-60(10)57)45-38(55)32(24)50)48-34(42(6,7)8)39(56)47-31(25(2)26-14-12-11-13-15-26)37(54)46-28(22-30(52)58-9)40-43-18-20-59-40/h11-15,18,20,24-25,27-28,31-34H,16-17,19,21-23H2,1-10H3,(H,44,48)(H,45,55)(H,46,54)(H,47,56)(H,49,53)/t24-,25+,27+,28-,31+,32+,33-,34-,60?/m1/s1 | Definition date: | 2019-10-21 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | methyl (3~{R})-3-[[(2~{S},3~{S})-2-[[(2~{S})-2-[(~{E})-[(6~{S},9~{S},12~{S},13~{R})-6-~{tert}-butyl-13-methyl-9-(2-methylsulfinylethyl)-2,8,11-tris(oxidanylidene)-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-5-ylidene]amino]-3,3-dimethyl-butanoyl]amino]-3-phenyl-butanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate |
|
![MRB MRB](https://data.pdbj.org/pdbjplus/data/cc/svg/MRB.svg) | MRB | Name: | Bottromycin A2 derivative | Formula: | C42 H62 N8 O7 S2 | SMILES: | COC(=O)C[CH](NC(=O)[CH](NC(=O)[CH](N=C1NCC(=O)N2CC[CH](C)[CH]2C(=O)N[CH](CCSC)C(=O)N[CH]1C(C)(C)C)C(C)(C)C)[CH](C)c3ccccc3)c4sccn4 | InChi: | InChI=1S/C42H62N8O7S2/c1-24-16-19-50-29(51)23-44-35(33(41(3,4)5)49-36(53)27(17-20-58-10)45-38(55)32(24)50)48-34(42(6,7)8)39(56)47-31(25(2)26-14-12-11-13-15-26)37(54)46-28(22-30(52)57-9)40-43-18-21-59-40/h11-15,18,21,24-25,27-28,31-34H,16-17,19-20,22-23H2,1-10H3,(H,44,48)(H,45,55)(H,46,54)(H,47,56)(H,49,53)/t24-,25+,27+,28-,31+,32+,33-,34-/m1/s1 | Definition date: | 2019-10-21 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | methyl (3~{R})-3-[[(2~{S},3~{S})-2-[[(2~{S})-2-[(~{E})-[(6~{S},9~{S},12~{S},13~{R})-6-~{tert}-butyl-13-methyl-9-(2-methylsulfanylethyl)-2,8,11-tris(oxidanylidene)-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-5-ylidene]amino]-3,3-dimethyl-butanoyl]amino]-3-phenyl-butanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate |
|
![MXK MXK](https://data.pdbj.org/pdbjplus/data/cc/svg/MXK.svg) | MXK | Name: | (2~{E})-2-hydroxyimino-~{N}-[(1~{S})-3-[4-[(2-methylimidazol-1-yl)methyl]-1,2,3-triazol-1-yl]-1-phenyl-propyl]ethanamid
e | Formula: | C18 H21 N7 O2 | SMILES: | Cc1nccn1Cc2cn(CC[CH](NC(=O)C=NO)c3ccccc3)nn2 | InChi: | InChI=1S/C18H21N7O2/c1-14-19-8-10-24(14)12-16-13-25(23-22-16)9-7-17(21-18(26)11-20-27)15-5-3-2-4-6-15/h2-6,8,10-11,13,17,27H,7,9,12H2,1H3,(H,21,26)/b20-11+/t17-/m0/s1 | Synonyms: | 2-(N-hydroxyimino)-N-[(1S)-3-{4-[(2-methyl-1H-imidazol-1-yl)methyl]-1H-1,2,3-triazol-1-yl}-1- phenylpropyl]acetamide | Definition date: | 2019-10-29 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2~{E})-2-hydroxyimino-~{N}-[(1~{S})-3-[4-[(2-methylimidazol-1-yl)methyl]-1,2,3-triazol-1-yl]-1-phenyl-propyl]ethanamide |
|
![O0Q O0Q](https://data.pdbj.org/pdbjplus/data/cc/svg/O0Q.svg) | O0Q | Name: | ~{N}-[2-(1,2,3-triazol-1-yl)ethyl]cubane-1-carboxamide | Formula: | C13 H14 N4 O | SMILES: | O=C(NCCn1ccnn1)C23C4C5C6C4C2C6C35 | InChi: | InChI=1S/C13H14N4O/c18-12(14-1-3-17-4-2-15-16-17)13-9-6-5-7(9)11(13)8(5)10(6)13/h2,4-11H,1,3H2,(H,14,18)/t5-,6+,7-,8+,9+,10-,11+,13+ | Definition date: | 2020-01-14 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | ~{N}-[2-(1,2,3-triazol-1-yl)ethyl]cubane-1-carboxamide |
|
![P5H P5H](https://data.pdbj.org/pdbjplus/data/cc/svg/P5H.svg) | P5H | Name: | 6-methyl-~{N}-[2-(methylsulfonylamino)ethyl]-2-oxidanylidene-3~{H}-pyridine-3-carboxamide | Formula: | C10 H15 N3 O4 S | SMILES: | CC1=NC(=O)[CH](C=C1)C(=O)NCCN[S](C)(=O)=O | InChi: | InChI=1S/C10H15N3O4S/c1-7-3-4-8(10(15)13-7)9(14)11-5-6-12-18(2,16)17/h3-4,8,12H,5-6H2,1-2H3,(H,11,14)/t8-/m0/s1 | Definition date: | 2020-04-15 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 6-methyl-~{N}-[2-(methylsulfonylamino)ethyl]-2-oxidanylidene-3~{H}-pyridine-3-carboxamide |
|
![P5W P5W](https://data.pdbj.org/pdbjplus/data/cc/svg/P5W.svg) | P5W | Name: | 4-[(4-phenyl-1,3-thiazol-2-yl)amino]benzoic acid | Formula: | C16 H12 N2 O2 S | SMILES: | OC(=O)c1ccc(Nc2scc(n2)c3ccccc3)cc1 | InChi: | InChI=1S/C16H12N2O2S/c19-15(20)12-6-8-13(9-7-12)17-16-18-14(10-21-16)11-4-2-1-3-5-11/h1-10H,(H,17,18)(H,19,20) | Definition date: | 2020-04-16 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | 4-[(4-phenyl-1,3-thiazol-2-yl)amino]benzoic acid |
|
![D8L D8L](https://data.pdbj.org/pdbjplus/data/cc/svg/D8L.svg) | D8L | Name: | (2R)-3-(1H-indol-3-yl)-2-methylsulfanyl-propanoic acid | Formula: | C12 H13 N O2 S | SMILES: | CS[CH](Cc1c[nH]c2ccccc12)C(O)=O | InChi: | InChI=1S/C12H13NO2S/c1-16-11(12(14)15)6-8-7-13-10-5-3-2-4-9(8)10/h2-5,7,11,13H,6H2,1H3,(H,14,15)/t11-/m1/s1 | Definition date: | 2019-07-19 | Last modified: | 2020-07-10 | Release date: | 2020-07-15 | Identifier: | (2~{R})-3-(1~{H}-indol-3-yl)-2-methylsulfanyl-propanoic acid |
|